The US Pain Medical Portfolio Lead (MPL) is an HQ-based Medical Affairs function positioned as the scientific interface between the Company and the external medical community. The US Pain MPL helps ensure the safe and effective use of the Company's medicines by supporting internal and external stakeholders with expertise related to the current portfolio, partnering internally on the development and launch of new products and indications, and generating new evidence. This role works with HQ commercial colleagues as part of a cross functional team to develop an overarching strategy. The US Pain MPL identifies areas of unmet medical need and develops in alignment with the US Pain Medical Lead Objectives, Strategies, Tactics, Metrics and Targets independent from commercial influence.